Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Clinical trial NCT01086540 · COMPLETED
Trial details
- NCT number
- NCT01086540
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-24
- Primary completion
- 2018-06-05
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.